Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet J ; 272: 105663, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33941337

ABSTRACT

Major crossmatch testing can help identify immunologic incompatibilities between blood donors and recipients; however, there are limited studies describing the accuracy of point-of-care crossmatch tests. The first aim of this study was to determine if a gel-based, point-of-care major crossmatch method (GEL-CM), without antiglobulin-enhancement, could accurately detect compatible and incompatible donor-recipient pairings, using an antiglobulin-enhanced laboratory-based major crossmatch method (LAB-CM) as the reference standard. The second aim was to describe the incidence of, and risk factors for, major crossmatch incompatibility in cats. Nineteen previously-transfused cats and 32 transfusion-naïve cats, representing 132 unique donor-recipient pairings, were included in this study. Both LAB-CM and GEL-CM tests were performed for most parings. There was poor agreement between the LAB-CM and GEL-CM results (kappa = 0.111; 95% confidence interval [CI], -0.093 to 0.314). Transfusion-naïve cats had incompatibility rates of 3% and 6% using LAB-CM and GEL-CM, respectively; previously-transfused cats had incompatibility rates of 32% and 26% using LAB-CM and GEL-CM, respectively. History of previous transfusion was the only identified cat risk factor for an incompatible LAB-CM (odds ratio [OR], 31.0; 95% CI, 3.77-254.98; P = 0.0019) and GEL-CM (OR, 5.7; 95% CI, 1.72-19.20; P = 0.0054). Further studies are needed to determine if GEL-CM can detect clinically-relevant immunologic incompatibilities that would result in transfusion reactions. Major crossmatch testing is of greater importance in cats that have previously received a transfusion.


Subject(s)
Anemia/veterinary , Blood Group Incompatibility/veterinary , Blood Grouping and Crossmatching/veterinary , Blood Transfusion/veterinary , Cat Diseases/therapy , Point-of-Care Systems/statistics & numerical data , Anemia/therapy , Animals , Blood Group Incompatibility/epidemiology , Blood Grouping and Crossmatching/statistics & numerical data , Cats , Female , Male , Prospective Studies , Risk Factors , Transfusion Reaction/epidemiology , Transfusion Reaction/veterinary
2.
Vet Pathol ; 42(1): 77-81, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15657276

ABSTRACT

This report describes the gross, microscopic, and immunohistochemical features of an invasive epithelial mesothelioma in an 11-year-old neutered male Golden Retriever. The tumor involved the pericardium, pleura, mediastinum, and peritoneum and invaded into submesothelial tissues. Neoplastic cells in the thoracic fluid showed prominent features of malignancy in a background of mixed inflammatory cells and scattered erythrocytes. Histologically, the tumor consisted of nests of epithelioid cells with frequent mitotic figures and multinucleation that infiltrated submesothelial tissues. Neoplastic cells strongly coexpressed vimentin and cytokeratin intermediate filaments, which assisted in the differentiation from other epithelial tumors of nonmesothelial origin.


Subject(s)
Dog Diseases/pathology , Mesothelioma/veterinary , Thoracic Neoplasms/veterinary , Animals , Antineoplastic Agents/therapeutic use , Carboplatin/therapeutic use , Dog Diseases/drug therapy , Dogs , Fatal Outcome , Male , Mesothelioma/drug therapy , Mesothelioma/pathology , Thoracic Neoplasms/drug therapy , Thoracic Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...